Quotes Frazier Lifesciences Acquisition Corporation
Equities
NAMS
NL00150012L7
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.9 EUR | -6.87% | +2.51% | +72.07% |
Quotes 5-day view
End-of-day quote Nasdaq2024-06-04 | 2024-06-05 | 2024-06-06 | 2024-06-07 | 2024-06-10 | |
---|---|---|---|---|---|
Last | 18.86 € | 19.22 € | 19.6 € | 19.3 € | 19.22 € |
Volume | 86 760 | 51 759 | 175 779 | 56 948 | 51 759 |
Change | -0.32% | +1.91% | +1.98% | -1.53% | -6.87% |
Opening | 18.92 | 19.05 | 19.38 | 19.52 | 19.05 |
High | 18.99 | 19.22 | 19.96 | 19.71 | 19.22 |
Low | 18.62 | 18.77 | 18.93 | 19.06 | 18.77 |
Performance
1 day | -6.87% | ||
1 week | +2.51% | ||
Current month | +2.51% | ||
1 month | -12.08% | ||
3 months | -8.35% | ||
6 months | +96.12% | ||
Current year | +72.07% | ||
1 year | +70.09% | ||
3 years | +95.13% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Bio Therapeutic Drugs
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-6.87% | +2.51% | +72.07% | +70.09% | 1.74B | ||
-0.51% | +6.08% | +18.72% | +44.58% | 125B | ||
+0.22% | +2.33% | +14.19% | +34.35% | 108B | ||
-1.44% | -0.26% | -4.93% | -8.16% | 24.21B | ||
-1.21% | +0.95% | +2.10% | -5.22% | 22.78B | ||
-0.06% | -1.15% | -10.39% | -28.48% | 17.96B | ||
-0.45% | +0.66% | -41.74% | -37.14% | 16.43B | ||
-0.79% | +5.05% | -13.31% | -27.62% | 16.37B | ||
+1.43% | -0.32% | +2.44% | +44.52% | 13.58B | ||
+5.01% | -5.04% | +27.89% | -3.41% | 11.66B | ||
-0.56% | +3.27% | +83.45% | +187.12% | 9.17B | ||
-2.13% | +13.90% | -24.26% | -32.61% | 8.31B | ||
-0.96% | +1.53% | +8.91% | +48.04% | 7.87B | ||
-2.12% | +1.00% | +13.01% | +40.37% | 7.72B | ||
-0.60% | -1.77% | -5.61% | +21.90% | 7.29B | ||
-1.15% | +14.81% | +37.58% | +49.73% | 6.47B | ||
Average | -0.76% | +3.06% | +11.26% | +24.88% | ||
Weighted average by Cap. | -0.28% | +3.41% | +10.20% | +26.42% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +72.78% | ||
2023 | +2.48% | ||
2022 | +11.79% | ||
2021 | -9.72% |
- Stock Market
- Equities
- NAMS Stock
- Quotes Frazier Lifesciences Acquisition Corporation